Email this page
Print
Bookmark and share
Bigger
Smaller
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
NPS RADAR January 2012NPS RADAR January 2012
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Find out more about NPS RADAR.
| Title | Why read this |
|---|---|
| Apixaban (Eliquis) for preventing venous thromboembolism after knee or hip replacement surgery Professional publication - NPS RADAR - Brief item | From 1 January 2012, apixaban (Eliquis) can be prescribed on the Pharmaceutical Benefits Scheme (PBS) for preventing venous thromboembolism (VTE) in people undergoing total knee or total hip replacement surgery. |
Complete list of all NPS RADAR content.
Find out more about NPS RADAR.
Date published: 2012-01-16 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
